News

rBIO Hits Key Lab Milestone with Synthetic Production of Insulin

January 04, 2021

Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.

Moderna and Recipharm Announce COVID-19 Vaccine Supply Agreement

January 04, 2021

The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States.

Honeywell to Acquire Sparta Systems for $1.3 Billion

January 04, 2021

Honeywell will use Sparta’s expertise to introduce new QMS solutions for life sciences to its customer base.

Phase III Trial of Novavax COVID-19 Trial Open for Enrollment in the US and Mexico

January 04, 2021

Part of Operation Warp Speed, the trial will enroll 30,000 people ages 18 to 64 and 65 and older at 115 sites.

The Outlook for a Year of Change

January 03, 2021

Despite the COVID-19 pandemic disruptions, with continued support and industry resilience, the European bio/pharma outlook for 2021 is positive.

Strategizing for Strength in EU Pharma

January 02, 2021

The recently published European pharmaceutical strategy is being seen as an opportunity to strengthen medicines regulation in the region.

A Bright Outlook

January 02, 2021

The outlook for the European pharma industry is appearing to be favourable overall.

Cytiva Opens New Manufacturing Facility in Massachusetts

January 01, 2021

Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors.

FDA Commissioner Takes a Look Back at 2020

December 31, 2020

Commissioner Stephen Hahn evaluates the agency’s response to COVID-19 and how it affected non-COVID related initiatives in 2020.

Florida Company Receives FDA Warning Letter

December 31, 2020

FDA sent a warning letter to Clientele for CGMP violations at the company’s Sunrise, FL facility that included a lack of an adequate quality unit.